Kindos Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KINDOS, and what generic and branded alternatives to KINDOS drugs are available?
KINDOS has eight approved drugs.
Drugs and US Patents for Kindos
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kindos | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 217348-001 | Jan 11, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kindos | THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 216037-002 | Dec 26, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kindos | LEUCOVORIN CALCIUM | leucovorin calcium | INJECTABLE;INJECTION | 216590-001 | Jul 19, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kindos | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 216040-002 | Dec 27, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kindos | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride | POWDER;IV (INFUSION) | 211001-001 | Jun 5, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Kindos | NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 216038-001 | Jan 10, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |